WINDLAS BIOTECH
Back to Balance Sheet
|
WINDLAS BIOTECH Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-0.28 Cr | ₹-0.57 Cr | ₹-2.03 Cr | ₹-2.04 Cr | ₹0.68 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of WINDLAS BIOTECH ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2025 | ₹-0.28 Cr |
Mar2024 | ₹-0.57 Cr |
Mar2023 | ₹-2.03 Cr |
Mar2022 | ₹-2.04 Cr |
Mar2021 | ₹0.68 Cr |
How is Deferred Tax Assets / Liabilities of WINDLAS BIOTECH Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹-0.28 Cr | Negative | |
Mar2024 | ₹-0.57 Cr | Negative | |
Mar2023 | ₹-2.03 Cr | Negative | |
Mar2022 | ₹-2.04 Cr | Negative | |
Mar2021 | ₹0.68 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of WINDLAS BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WINDLAS BIOTECH | ₹2,197.3 Cr | 14.1% | 11.9% | 36.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹394,115.0 Cr | 3.5% | -3.4% | -5.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,735.0 Cr | 3.7% | -10.2% | 25.6% | Stock Analytics | |
CIPLA | ₹126,313.0 Cr | 5.3% | 6.1% | -1.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,592.0 Cr | 1.4% | 4.6% | 7.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,095.0 Cr | 3.9% | 0% | -9.9% | Stock Analytics |
WINDLAS BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WINDLAS BIOTECH | 14.1% |
11.9% |
36.6% |
SENSEX | -0% |
-2.4% |
1.2% |
You may also like the below Video Courses